GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jetblack JTBK · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

—

FY2015FY2024

Net income

−$456,530

FY2015FY2024

Free cash flow

$93,740

FY2015FY2024

Shareholders' equity

−$2.8m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue———$1,934$400———$250—
Operating income−$456,530−$461,511−$463,020−$401,120−$464,420−$458,220−$319,040−$181,320−$35,587−$12,000
Net income−$456,530−$436,511−$463,015−$401,114−$464,422−$499,239−$320,423−$189,368−$35,587−$12,000
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$99,167$99,531$74,852$68,680$114,069$99,413$192,002$360,438$21,232—
Cash and short-term investments$83$447$768———$6,468−$4,073$2,561—
Total liabilities$2.9m$2.4m$1.9m$1.5m$1.1m$623,506$217,719$65,731$86,819$48
Debt——————$213,748$74,514$79,789$48
Shareholders' equity−$2.8m−$3.1m−$1.9m−$1.4m−$988,516−$524,093−$25,717$294,707−$65,587−$48
Shares outstanding323m275m275m615m860m615m615m703m442m860m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations$93,745$173,487$40,160−$1,777−$189,061−$80,127−$129,065−$551,020$19,465−$12,000
Capital spending−$5———————−$7,255−$7,255
Free cash flow$93,740$173,487$40,160−$1,777−$189,061−$80,127−$129,065−$551,020$12,210−$19,255

Latest quarters

By quarter end

Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023
Operating income−$2,719−$136,164−$113,334−$112,023−$112,283−$118,890−$87,090−$112,640
Net income−$68,791−$136,164−$113,334−$112,023−$112,283−$118,890−$87,088−$112,641
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$38,605$99,169$99,167$99,308$99,109$99,071$99,531$74,239
Cash and short-term investments$200$85$83$224$25−$12$447$155
Shareholders' equity−$3.0m−$2.9m−$2.8m−$2.7m−$2.6m−$2.5m−$3.1m−$2.2m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income4.4%-0.1%53.7%
Net income4.4%-1.8%55.8%

Valuation history

At each fiscal year end

FY2024FY2023FY2021FY2020FY2016FY2015
Price to earnings-0.2-0.0-0.0——-0.0
Price to sales——1.72.40.3—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-52%135%1735%-47%402%812%-78%310%18%-2%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 6-for-1 split · 5 Apr 2010
  • 9-for-1 split · 9 Apr 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.